Get the Stockscreener App
9.75
4.06%
0.38
Why is Apollomics Inc (APLM) Stock down?
We've noticed a 8.87% decline in Apollomics Inc (APLM) stock during the 2024-12-17 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
23 Oct, 2023:
Apollomics Inc Stock (APLM) dropped by 43.24% from $1.75 to $0.9933 in the trading on Monday October 23, 2023. The reason why APLM stock down today is due to the presentation of vebreltinib efficacy and safety data. Apollomics announced the vebreltinib efficacy and safety data from the KUNPENG clinical trial at ESMO 2023 in NSCLC patients with MetEx14 skipping mutation, achieving an overall response rate (ORR) of 75%.
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):